polatuzumab vedotin,vedolizumab
takeda,roche
['omg', 'polatuzumab', 'lymsm', 'lymphoma', ' vedo']
polarice is tolerable in second line but confirms difficult response in primary refractory patients #lymsm #bmtsm #ash22 
A hematologist @MoffittNews with interest in #lymsm. Tweets are not endorsements, and not medical advice.